336 related articles for article (PubMed ID: 19395969)
21. [Accelerated desensitization to lung allergens].
Michel FB; Guerin B; Bousquet J
Tunis Med; 1984; 62(3):201-7. PubMed ID: 6528396
[No Abstract] [Full Text] [Related]
22. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
23. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
Grier TJ
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
[TBL] [Abstract][Full Text] [Related]
24. Allergen immunotherapy: where is it now?
Nelson HS
J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297
[TBL] [Abstract][Full Text] [Related]
25. [Specific immunotherapy. Subcutaneous or sublingual?].
Stiefelhagen P
MMW Fortschr Med; 2008 Jun; 150(24):14, 16. PubMed ID: 18605053
[No Abstract] [Full Text] [Related]
26. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
Bukantz SC; Bagg AS; Lockey RF
Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
[No Abstract] [Full Text] [Related]
27. Novel approaches in treating food allergy using allergens.
Rancé F
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():157-63; discussion 164-7, 251-7. PubMed ID: 19710521
[TBL] [Abstract][Full Text] [Related]
28. Lack of latex allergen contamination of solutions withdrawn from vials with natural rubber stoppers.
Thomsen DJ; Burke TG
Am J Health Syst Pharm; 2000 Jan; 57(1):44-7. PubMed ID: 10630556
[TBL] [Abstract][Full Text] [Related]
29. The safety of multi-dose vials in allergy immunotherapy.
Lin SY; Lay PC; Hughes LF; Bass R
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):195-7. PubMed ID: 18656714
[TBL] [Abstract][Full Text] [Related]
30. Allergen immunotherapy in allergic respiratory disease in childhood.
Kumar L
Indian J Pediatr; 1989; 56(4):473-8. PubMed ID: 2699312
[No Abstract] [Full Text] [Related]
31. End-preparation assessments and tests for compounded sterile preparations.
McElhiney LF
Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
[TBL] [Abstract][Full Text] [Related]
32. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
33. Basics of sterile compounding: compounding by weight versus compounding by volume.
Thoma L
Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
[TBL] [Abstract][Full Text] [Related]
34. How to stop the allergy march.
Lopes Dos Santos JM
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107
[No Abstract] [Full Text] [Related]
35. [Practical problems in specific hyposensitization].
Oehling A
Med Klin; 1972 Jul; 67(29):983-8. PubMed ID: 5051382
[No Abstract] [Full Text] [Related]
36. Issues in stinging insect allergy immunotherapy: a review.
Finegold I
Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592
[TBL] [Abstract][Full Text] [Related]
37. Instructions and consent forms for subcutaneous allergen immunotherapy.
Cox L; Lockey RF
Clin Allergy Immunol; 2008; 21():499-525. PubMed ID: 18828526
[No Abstract] [Full Text] [Related]
38. Safety of home-based and office allergy immunotherapy: A multicenter prospective study.
Hurst DS; Gordon BR; Fornadley JA; Hunsaker DH
Otolaryngol Head Neck Surg; 1999 Nov; 121(5):553-61. PubMed ID: 10547469
[TBL] [Abstract][Full Text] [Related]
39. Accelerated immunotherapy schedules and premedication.
Calabria CW; Cox L
Immunol Allergy Clin North Am; 2011 May; 31(2):251-63, ix. PubMed ID: 21530818
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of oromucosal immunotherapy in respiratory allergy.
Brown JL; Frew AJ
Clin Exp Allergy; 2001 Jan; 31(1):8-10. PubMed ID: 11167944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
